Heard D J, Nichols W W, Buss D, Kollias G V
Department of Small Animal Clinical, University of Florida, Gainesville 32610, USA.
Am J Vet Res. 1996 Jan;57(1):87-96.
To determine comparative cardiopulmonary effects of IM administered etorphine and carfentanil in goats.
Seven clinically normal adult female goats.
Each goat received at least 9 drug treatments (etorphine HCl, 5 [twice], 10, 20, and 40 and carfentanil citrate, 5, 10, 20 and 40 micrograms/kg of body weight), with a minimal 2-day interval between trials. Although drug dosages were randomized, etorphine and carfentanil treatments were alternated. To assess for drug tolerance, the first and last treatments always were etorphine (5 micrograms/kg).
All goats were instrumented for long-term cardiopulmonary variable data collection.
Both drugs induced rapid catatonic immobilization, characterized by limb and neck hyperextension, with occasional vocalization and bruxation. Etorphine elicited transient violent struggling and vocalization immediately. Time to immobilization appeared dose-dependent, and was more rapid with carfentanil (< or = 5 minutes) than etorphine (5 to 10 minutes) at all dosages. Recovery to standing occurred earlier for etorphine (1 to 2 hours) than carfentanil (> 2 hours) at all dosages. Both drugs at all dosages significantly (P < or = 0.05) increased systemic and left ventricular (LV) end-diastolic pressures, LV peak negative dP/dt, total peripheral resistance (TPR), hemoglobin concentration, and left atrial (LA) and pulmonary O2 contents. They also significantly decreased heart and respiration rates, and TPR. A significant increase was observed at some dosages for LV stroke volume and index, LV peak positive dP/dt, mean pulmonary artery pressure, PaO2, pulmonary artery oxygen partial pressure, PaCO2, pulmonary mixed venous carbon dioxide partial pressure, LA hemoglobin saturation, LA transport index, and body temperature. Pulmonary and systemic mixed venous carbon dioxide and oxygen contents were significantly decreased at some dosages.
Intramuscularly administered etorphine and carfentanil induce hypertension, bradycardia, and bradypnea in goats. The hypertension appears attributable to an increase in TPR.
Although the cardiopulmonary effects of carfentanil occurred more rapidly, these effects were similar in magnitude for etorphine and carfentanil over the evaluated dosage range.
确定肌肉注射埃托啡和卡芬太尼对山羊心肺功能的比较影响。
7只临床健康的成年雌性山羊。
每只山羊接受至少9次药物治疗(盐酸埃托啡,5[两次]、10、20和40以及枸橼酸卡芬太尼,5、10、20和40微克/千克体重),试验间隔至少2天。尽管药物剂量是随机的,但埃托啡和卡芬太尼治疗交替进行。为评估药物耐受性,第一次和最后一次治疗始终为埃托啡(5微克/千克)。
所有山羊均安装仪器以进行长期心肺变量数据收集。
两种药物均诱导快速的强直性麻痹,其特征为肢体和颈部过度伸展,偶尔伴有发声和磨牙。埃托啡立即引发短暂的剧烈挣扎和发声。麻痹时间似乎呈剂量依赖性,在所有剂量下,卡芬太尼导致麻痹的速度更快(≤5分钟),而埃托啡则为5至10分钟。在所有剂量下,埃托啡恢复站立的时间(1至2小时)比卡芬太尼(>2小时)更早。所有剂量的两种药物均显著(P≤0.05)增加全身和左心室(LV)舒张末期压力、LV最大负向dP/dt、总外周阻力(TPR)、血红蛋白浓度以及左心房(LA)和肺O2含量。它们还显著降低心率和呼吸频率以及TPR。在某些剂量下,观察到LV每搏输出量和指数、LV最大正向dP/dt、平均肺动脉压、PaO2、肺动脉氧分压、PaCO2、肺混合静脉二氧化碳分压、LA血红蛋白饱和度、LA转运指数和体温有显著增加。在某些剂量下,肺和全身混合静脉二氧化碳和氧含量显著降低。
肌肉注射埃托啡和卡芬太尼可导致山羊高血压、心动过缓和呼吸过缓。高血压似乎归因于TPR增加。
尽管卡芬太尼的心肺效应出现得更快,但在评估的剂量范围内,埃托啡和卡芬太尼的这些效应在程度上相似。